Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
B

Beta Bionics Inc
NASDAQ:BBNX

Watchlist Manager
Beta Bionics Inc
NASDAQ:BBNX
Watchlist
Price: 13.8699 USD 6.04% Market Closed
Market Cap: $610.6m
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

BBNX Price Targets Summary
Beta Bionics Inc

Wall Street analysts forecast BBNX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BBNX is 29.9509 USD with a low forecast of 17.17 USD and a high forecast of 42 USD.

BBNX Lowest Forecast
Wall Street Target
17.17 USD
24% Upside
BBNX Average Forecast
Wall Street Target
29.9509 USD
116% Upside
BBNX Highest Forecast
Wall Street Target
42 USD
203% Upside
Lowest
Price Target
17.17 USD
24% Upside
Average
Price Target
29.9509 USD
116% Upside
Highest
Price Target
42 USD
203% Upside
Beta Bionics Inc Competitors:
Price Targets
VIB3
Villeroy & Boch AG
36% Upside
GNL
Global Net Lease Inc
0% Downside
IP
International Paper Co
1% Upside
URI
United Rentals Inc
11% Upside
VIB3
Villeroy & Boch AG
36% Upside
GNL
Global Net Lease Inc
0% Downside
IP
International Paper Co
1% Upside
URI
United Rentals Inc
11% Upside

Revenue
Forecast

443% / Year
Past Growth
41% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
443% / Year
Past Growth
41% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

For the last 1 year the compound annual growth rate for Beta Bionics Inc's revenue is 443%. The projected CAGR for the next 4 years is 41%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

What are analyst estimates?

See Also

Summary
BBNX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BBNX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BBNX stock valuation using valuation multiples.
Wall Street Estimates
BBNX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BBNX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BBNX's stock price target?
Price Target
29.9509 USD

According to Wall Street analysts, the average 1-year price target for BBNX is 29.9509 USD with a low forecast of 17.17 USD and a high forecast of 42 USD.

What is Beta Bionics Inc's Revenue forecast?
Projected CAGR
41%

For the last 1 year the compound annual growth rate for Beta Bionics Inc's revenue is 443%. The projected CAGR for the next 4 years is 41%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 316,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.